Formoterol
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption=' | + | <StructureSection load='' size='340' side='right' caption='Formoterol' scene='96/963800/Cv/1'> |
| - | Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β2 agonists such as salbutamol (albuterol), which are effective for 4 h to 6 h. Formoterol has a relatively rapid onset of action compared to other LABAs, and is effective within 2-3 minutes. See also [https://en.wikipedia.org/wiki/Formoterol]. | + | Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β2 agonists such as [[salbutamol]] (albuterol), which are effective for 4 h to 6 h. Formoterol has a relatively rapid onset of action compared to other LABAs, and is effective within 2-3 minutes. See also [https://en.wikipedia.org/wiki/Formoterol]. |
| + | |||
| + | <scene name='96/963800/Overall/1'>Adrenoceptor with bound agonist formoterol</scene> ([[6tko]]). | ||
| + | |||
| + | <scene name='96/963800/Surfacecavity/2'>Ligand binding cavity</scene>. | ||
| + | |||
| + | <scene name='96/963800/Binding_site/2'>Formoterol binding site</scene>. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Current revision
| |||||||||||
